Innate Pharma (IPHA) Reports FY22, Provides Business Update

Go back to Innate Pharma (IPHA) Reports FY22, Provides Business Update
(NASDAQ: IPHA) Delayed: 1.70 --0 (-0%)
Previous Close $1.70    52 Week High $ 
Open $1.70    52 Week Low $ 
Day High $1.70    P/E N/A 
Day Low $1.70    EPS $ 
Volume 115